Detalles de la búsqueda
1.
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 18(1): 63-74, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914822
2.
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Blood
; 124(15): 2400-7, 2014 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25145343
3.
FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.
Blood
; 121(7): 1083-93, 2013 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23243289
4.
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.
Br J Haematol
; 166(2): 254-259, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24661089
5.
Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation.
Pediatr Blood Cancer
; 61(2): 269-75, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23955900
6.
Proactive enteral tube feeding in pediatric patients undergoing chemotherapy.
Pediatr Blood Cancer
; 61(2): 281-5, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24019241
7.
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(4): 647-52, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24127439
8.
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.
Blood Adv
; 8(9): 2094-2103, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38295280
9.
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.
Cancer
; 119(23): 4162-9, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24104395
10.
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.
Blood
; 117(26): 7007-13, 2011 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21518931
11.
Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 60(12): 2073-8, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24039149
12.
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood
; 116(5): 702-10, 2010 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20413658
13.
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
Blood
; 115(12): 2372-9, 2010 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20056794
14.
Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 58(4): 519-24, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21618422
15.
Germline genetic variation and treatment response on CCG-1891.
Pediatr Blood Cancer
; 58(5): 695-700, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21618417
16.
Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML.
Pediatr Blood Cancer
; 59(5): 922-4, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22517793
17.
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood
; 113(26): 6558-66, 2009 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19304957
18.
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Pediatr Blood Cancer
; 57(3): 398-405, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21681921
19.
A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.
Front Oncol
; 11: 744739, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34540703
20.
Structural and numerical variation of FLT3/ITD in pediatric AML.
Blood
; 111(10): 4930-3, 2008 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18305215